How should I modify my insulin therapy for an A1c of 10.1% while on a sliding‑scale insulin lispro (Humalog) and insulin glargine 40 units twice daily?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 5, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Insulin Therapy Modification for A1c 10.1%

You need to intensify your insulin regimen immediately by adding scheduled prandial insulin (not just sliding scale) to your basal glargine, starting with one dose of rapid-acting insulin before your largest meal, then titrating up to a full basal-bolus regimen if needed. 1

Critical Problem with Current Regimen

Your current regimen has two major issues:

  1. Glargine 40 units BID is incorrect dosing - Glargine is designed as a once-daily basal insulin, not twice daily 2. You're essentially getting 80 units/day of basal insulin, which suggests possible "overbasalization" without adequate prandial coverage.

  2. Sliding scale alone is inadequate - Reactive correction insulin without scheduled mealtime doses fails to address postprandial hyperglycemia, which is why your A1c remains at 10.1% despite high basal doses.

Recommended Restructuring Algorithm

Step 1: Convert to Once-Daily Basal Insulin

  • Consolidate your glargine to 60-70 units once daily (reducing from 80 units total to account for adding prandial coverage) 1
  • Administer at the same time each day (morning or bedtime - your choice for adherence) 2
  • If A1c <8%, consider reducing basal by 4 units or 10% when adding prandial insulin 1

Step 2: Add Scheduled Prandial Insulin

Start with 4 units of Humalog before your largest meal (typically dinner) OR 10% of your basal dose 1

  • This is NOT sliding scale - this is scheduled, fixed-dose prandial insulin
  • Titrate by 1-2 units or 10-15% every 3 days based on 2-hour postprandial glucose 1
  • Target postprandial glucose <180 mg/dL

Step 3: Expand Prandial Coverage if Needed

If A1c remains >7% after 3 months:

  • Add prandial insulin to second-largest meal (4 units or 10% of basal)
  • Eventually progress to full basal-bolus (insulin before all three meals) 1

Alternative: Consider GLP-1 RA First

Before intensifying insulin further, strongly consider adding a GLP-1 receptor agonist (like semaglutide or dulaglutide) to your current regimen 1. This is particularly important because:

  • At A1c >10%, GLP-1 RAs can reduce A1c by 2-3% 3
  • They cause weight loss instead of the weight gain you'll get with more insulin 1
  • Lower hypoglycemia risk compared to intensive insulin 4
  • May actually be superior to insulin intensification at your A1c level 3

If you add a GLP-1 RA, reduce your basal insulin by 10-20% to prevent hypoglycemia 1.

Critical Monitoring Points

  • Check fasting glucose to titrate basal insulin (target 80-130 mg/dL)
  • Check 2-hour postprandial glucose to titrate prandial insulin (target <180 mg/dL)
  • Assess for overbasalization signs: large bedtime-to-morning glucose differential, hypoglycemia, high glucose variability 1
  • Prescribe glucagon for emergency hypoglycemia 1

Common Pitfalls to Avoid

  1. Don't continue glargine BID - this is not evidence-based dosing 2
  2. Don't rely on sliding scale alone - it's reactive, not preventive
  3. Don't delay intensification - therapeutic inertia at A1c 10.1% increases complication risk 1
  4. Don't forget to reduce basal when adding prandial - prevents excessive total daily dose and hypoglycemia 1

Reassessment Timeline

  • Titrate insulin doses every 3 days based on glucose patterns 1
  • Reassess A1c in 3 months 1
  • If still not at goal, continue stepwise intensification to full basal-bolus regimen 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.